Definitive Contraception: Trends in a Ten-year Interval

Abstract

Objective To evaluate the trends in definitive contraception in a ten-year interval comprising the years 2002 and 2012.

Method Retrospective analysis of the tubal sterilization performed in our service in 2002 and 2012, analyzing the demographic characteristics, personal history, previous contraceptive method, definite contraception technique, effectiveness and complications.

Results Definitive contraception was performed in 112 women in 2002 (group 1) and in 60 women in 2012 (group 2). The groups were homogeneous regarding age, parity, educational level and personal history. The number of women older than 40 years choosing a definitive method was more frequent in group 1, 49.1% (n = 55); for group 2, the rate was 34.8% (n = 23) (p = 0.04). The time between the last delivery and the procedure was 11.6 ± 6.2 and 7.9 ± 6.4 years (p = 0.014) in 2002 against 2012 respectively. In 2002, all patients performed tubal ligation by laparoscopic inpatient regime. In 2012, the bilateral placement of the Essure (Bayer Corporation, Whippany, NJ, US) device was suggested to 56.1% (n = 37) of the patients, while laparoscopy was suggested to 43.9% (n = 29) of them. All women who underwent laparoscopic sterilization had the procedure successfully completed using silastic rings. The overall bilateral device placement rate for the Essure was 91.6%, with only one complication reported. All Essure procedures were performed in an outpatient setting; for the laparoscopy, this rate was 79% (n = 15). No intentional pregnancies occurred until this date.

Conclusions There is a trend in the decrease in definitive contraception over the years in our institution, maybe as a result of the development of long-acting reversible contraceptives. The hysteroscopic procedure has become a frequent option, as it is performed in an office setting without anesthesia, being a well-tolerated, minimal invasive method.

Resumo

Objetivo Avaliar as tendências da contracepção definitiva feminina num intervalo de 10 anos, 2002 e 2012.

Métodos Análise retrospectiva das mulheres submetidas a esterilização em 2002 e 2012 no Serviço de Ginecologia de um hospital em Portugal, atendendo às caraterísticas demográficas, antecedentes pessoais, método contraceptivo prévio, técnica de contracepção efetuada, eficácia e complicações ocorridas.

Resultados Foram submetidas a contracepção definitiva 112 mulheres em 2002 (grupo 1), e 66 em 2012 (grupo 2). Os grupos eram semelhantes na idade, paridade, nível educacional e antecedentes pessoais. O número de mulheres com mais de 40 anos que optou por um método definitivo foi superior no grupo 1, 49,1% (n = 55), versus 34,8% (n = 23) no grupo 2 (p = 0,04). O tempo decorrido entre o último parto e o procedimento foi de 11.6 ± 6.2 anos e 7.9 ± 6.4 anos (p = 0.014) em 2002 versus 2012, respetivamente. Em 2002, todas as mulheres foram submetidas a laqueação tubária em regime de internamento. Em 2012, a colocação bilateral do Essure (Bayer Corporation, Whippany, NJ, EUA) foi proposta para 56,1% (n = 37) das pacientes, enquanto a laparoscopia foi proposta para 43,9% (n = 29) delas. A laqueação por laparoscopia foi realizada com sucesso em todos os casos com anéis de silastic. A taxa de colocação bilateral do Essure foi de 91,6%, tendo sido registrada uma complicação. Todos os procedimentos com Essure foram realizados em regime de ambulatório, enquanto que tal se verificou em 79% (n = 15) daquelas pacientes submetidas a laparoscopia. Não ocorreram gravidezes não intencionais.

Conclusão Parece haver uma tendência para a diminuição da esterilização como opção contraceptiva, provavelmente devido à disponibilidade de diversos métodos contraceptivos de longa duração aliada aos benefícios não contraceptivos. A opção pelo dispositivo Essure, mais recentemente, é justificada pela sua realização em contexto de consultório, sem anestesia, sendo um método minimamente invasivo e bem tolerado.

Keywords

definitive contraception - tubal ligation - office hysteroscopy - essure

Palavras-chave

contracepção definitiva - laqueadura tubária - histeroscopia - essure

• References

• 1 United Nations. Department of Economic and Social Affairs, Population Division [Internet]. Trends in contraceptive use worldwide 2015. 2015 [cited 2016 Jan 20]. Available from: http://www.un.org/en/development/desa/population/publications/pdf/family/trendsContraceptiveUse2015Report.pdf
• 2 Águas F, Bombas T, Pereira da Silva D. Evaluation on portuguese women contraceptive practice. Acta Ginecol Obstet Port 2016; 10 (03) 184-192
• 3 Chan LM, Westhoff CL. Tubal sterilization trends in the United States. Fertil Steril 2010; 94 (01) 1-6
• 4 Cullen KA, Hall MJ, Golosinskiy A. Ambulatory surgery in the United States, 2006. Natl Health Stat Rep 2009; 11 (11) 1-25
• 5 Castaño PM, Adekunle L. Transcervical sterilization. Semin Reprod Med 2010; 28 (02) 103-109
• 6 Osathanondh V. Suprapubic mini-laparotomy, uterine elevation technique: simple, inexpensive and out-patient procedure for interval female sterilization. Contraception 1974; 10 (03) 251-262
• 7 Ubeda A, Labastida R, Dexeus S. Essure: a new device for hysteroscopic tubal sterilization in an outpatient setting. Fertil Steril 2004; 82 (01) 196-199
• 8 Trussell J. Contraceptive failure in the United States. Contraception 2011; 83 (05) 397-404
• 9 Peterson HB, Xia Z, Hughes JM, Wilcox LS, Tylor LR, Trussell J. The risk of pregnancy after tubal sterilization: findings from the U.S. Collaborative Review of Sterilization. Am J Obstet Gynecol 1996; 174 (04) 1161-1168 , discussion 1168–1170
• 10 Rattray D, Thiel P, Suchet I, Thiel J. Confirmation testing of Essure microinserts in unintended pregnancies using a 10-year retrospective database. J Minim Invasive Gynecol 2016; 23 (06) 944-948
• 11 Stewart A, Cummins C, Gold L, Jordan R, Phillips W. The effectiveness of the levonorgestrel-releasing intrauterine system in menorrhagia: a systematic review. BJOG 2001; 108 (01) 74-86
• 12 Levie M, Weiss G, Kaiser B, Daif J, Chudnoff SG. Analysis of pain and satisfaction with office-based hysteroscopic sterilization. Fertil Steril 2010; 94 (04) 1189-1194
• 13 Levie MD, Chudnoff SG. Prospective analysis of office-based hysteroscopic sterilization. J Minim Invasive Gynecol 2006; 13 (02) 98-101
• 14 Famuyide AO, Hopkins MR, El-Nashar SA. , et al. Hysteroscopic sterilization in women with severe cardiac disease: experience at a tertiary center. Mayo Clin Proc 2008; 83 (04) 431-438
• 15 Panel P, Grosdemouge I. Predictive factors of Essure implant placement failure: prospective, multicenter study of 495 patients. Fertil Steril 2010; 93 (01) 29-34
• 16 Miño M, Arjona JE, Cordón J, Pelegrin B, Povedano B, Chacon E. Success rate and patient satisfaction with the Essure sterilisation in an outpatient setting: a prospective study of 857 women. BJOG 2007; 114 (06) 763-766
• 17 la Chapelle CF, Veersema S, Brölmann HA, Jansen FW. Effectiveness and feasibility of hysteroscopic sterilization techniques: a systematic review and meta-analysis. Fertil Steril 2015; 103 (06) 1516-25.e1 , 3
• 18 Adelman MR, Dassel MW, Sharp HT. Management of complications encountered with Essure hysteroscopic sterilization: a systematic review. J Minim Invasive Gynecol 2014; 21 (05) 733-743
• 19 Thiel JA, Lukwinski A, Kamencic H, Lim H. Oral analgesia vs intravenous conscious sedation during Essure Micro-Insert sterilization procedure: randomized, double-blind, controlled trial. J Minim Invasive Gynecol 2011; 18 (01) 108-111
• 20 Gordts S, Campo R, Puttemans P, Gordts S. Clinical factors determining pregnancy outcome after microsurgical tubal reanastomosis. Fertil Steril 2009; 92 (04) 1198-1202
• 21 Monteith CW, Berger GS, Zerden ML. Pregnancy success after hysteroscopic sterilization reversal. Obstet Gynecol 2014; 124 (06) 1183-1189
• 22 Thiel J, Rattray D, Cher DJ. Pre-hysterectomy assessment of immediate tubal occlusion with the third-generation ESSURE insert (ESS505). J Minim Invasive Gynecol 2014; 21 (06) 1055-1060
• 23 Erickson BK, Conner MG, Landen Jr CN. The role of the fallopian tube in the origin of ovarian cancer. Am J Obstet Gynecol 2013; 209 (05) 409-414
• 24 Bollapragada SS, Bandyopadhyay S, Serle E, Baird C. Spontaneous pregnancy after bilateral salpingectomy. Fertil Steril 2005; 83 (03) 767-768
• 25 Morelli M, Venturella R, Mocciaro R. , et al. Prophylactic salpingectomy in premenopausal low-risk women for ovarian cancer: primum non nocere. Gynecol Oncol 2013; 129 (03) 448-451